Anti-COVID-19 vaccination may have functional implications for immune checkpoint inhibitor treatment in patients with cancer. This study was undertaken to determine whether the safety or efficacy of anti-PD-1 therapy is reduced in patients with cancer during COVID-19 vaccination. A large multicenter …
Full Story:
https://pubmed.ncbi.nlm.nih.gov/35264438/
https://pubmed.ncbi.nlm.nih.gov/35264438/